Cynthia Collins is the founder of Editas Medicine. Editas Medicine has raised $214M in total funding. Latest round: IPO. Backed by Bill Gates.
Cynthia Collins serves as President and a member of the Board of Directors at Editas Medicine, a clinical-stage biotechnology company developing CRISPR-based gene editing therapies. She was appointed to the Board of Directors and later named President of the company, contributing to its leadership in rare disease therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library